Skip to content
AFL$121.38-0.61(-0.50%)My Special Aflac Duck® Puts Love and Care in the hands of Children at Riley Hospital Children receiving care for cancer and blood disorders at Riley Hospital for Children in Indianapolis have a new companion to help bring comfort and...[9:40:00 AM ET]GMAB$49.77+5.10(+11.42%)Genmab Announces Statistically Significant, Clinically Meaningful Improvement in Overall Survival and Objective Response with Petosemtamab Combination at First Interim Analysis in First-Line R/M Patients with PD-L1+ Head and Neck Cancer[9:40:00 AM ET]FGPR$20.21+0.01(+0.05%)Ferrellgas and Operation Warm to Give More Than 350 Flagstaff Children New Winter Coats[9:30:00 AM ET]FGPR$20.21+0.01(+0.05%)Ferrellgas and Operation Warm to Give 350 Bay City Children New Winter Coats[9:30:00 AM ET]JXN$134.77-0.30(-0.22%)QVT Issues Second Report on Jackson Financial (JXN) Subsidiary Brooke Life Reinsurance Co. Underscoring Near-Term Liquidity Challenges[9:30:00 AM ET]APH$80.10+1.89(+2.42%)Industrial Growth Partners Announces Sale of AdvancedPCB Industrial Growth Partners ("IGP") is pleased to announce that it has entered into a definitive agreement to sell AdvancedPCB Holdings, LLC...[9:27:00 AM ET]BLGO$0.07-0.00(-3.62%)BioLargo Introduces barebird, a Company-Owned Brand, Reuniting Key Teams Behind Pooph's Consumer Market Success[9:25:00 AM ET]TWOSF$0.24-0.00(-0.04%)T2 Metals to Attend the 52nd Annual New Orleans Investment Conference[9:25:00 AM ET]MOB$3.32+0.03(+0.91%)Mobilicom to Showcase Cybersecure Portfolio Highlighting Newly Launched SwarmiX at ARC WEPTAC Conference[9:22:00 AM ET]COSM$0.25+0.01(+5.72%)Noble Capital Markets Initiates Equity Research Coverage on Cosmos Health with Outperform Rating and $1.40 Price Target[9:20:00 AM ET]MGN$3.40+0.34(+11.11%)Megan Holdings Limited Announces Pricing of Up to $7.5 Million Follow-on Public Offering[9:20:00 AM ET]ADSE$9.36+0.06(+0.65%)ADS-TEC Energy Advances One of Europe's Largest Battery Storage Projects as Building Permit Nears[9:18:00 AM ET]ELS$58.45-1.04(-1.75%)ELS Declares Fourth Quarter 2026 Dividend On October 27, 2026, the Board of Directors of Equity LifeStyle Properties, Inc. (NYSE: ELS) (referred to herein as "we," "us," and "our") declared a ...[9:18:00 AM ET]IREN$27.19-0.25(-0.91%)IREN and Wingspire Equipment Finance Complete $363 Million Financing for High-Density AI Compute Assets[9:17:00 AM ET]GSAT$83.89-0.01(-0.01%)XCOM RAN Wins the Gold Stevie® 2026 Award for Technology Excellence[9:16:00 AM ET]

COCH · NASDAQ

Envoy Medical, Inc.

$6.24 -0.27 (-4.15%)

Company overview

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. The company was founded in 1995 and is based in White Bear Lake, Minnesota. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004.

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Market cap
$482M
Employees
42
Headquarters
White Bear Lake, MN
CEO
Brent T. Lucas
Listed
April 29, 2021
P/E
-6.10
Dividend yield
0.00%

Company financials

Revenue
$234,000
Gross profit
-$727,000
Operating income
-$23.1M
EBITDA
-$23.3M
Net income
-$23.1M
EPS
-$1.02
Total assets
$29.8M
Total debt
$889,000
Gross margin
-310.68%
Net margin
-9,875.64%
Earnings yield
-16.39%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

No geographic segmentation.

Showing FY 2025

Price chart

0.282.033.795.557.31
COCH 1D NASDAQ O6.41H7.05L6.02C6.51+0.01 (+0.15%)Vol15.33K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
COCHEnvoy Medical, Inc. Press release Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th Newsfile
COCHEnvoy Medical, Inc. Press release Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th Newsfile
COCHEnvoy Medical, Inc. Press release Envoy Medical Announces Reverse Stock Split Newsfile
COCHEnvoy Medical, Inc. Press release Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design Newsfile
COCHEnvoy Medical, Inc. Press release Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant Newsfile
COCHEnvoy Medical, Inc. Press release Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio Newsfile
COCHEnvoy Medical, Inc. Press release Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th Newsfile
COCHEnvoy Medical, Inc. Stock news Are Medical Stocks Lagging Compugen (CGEN) This Year? Zacks Investment Research
COCHEnvoy Medical, Inc. Stock news Envoy Medical (NASDAQ:COCH) vs. American Bio Medica (OTCMKTS:ABMC) Critical Review Defense World
COCHEnvoy Medical, Inc. Stock news Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates Zacks Investment Research
COCHEnvoy Medical, Inc. Press release Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones Newsfile Corp
COCHEnvoy Medical, Inc. Stock news Envoy Medical, Inc. (COCH) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks Investment Research
COCHEnvoy Medical, Inc. Press release Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial Newsfile Corp
COCHEnvoy Medical, Inc. Stock news Is Humana (HUM) Stock Outpacing Its Medical Peers This Year? Zacks Investment Research
COCHEnvoy Medical, Inc. Press release Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th Newsfile Corp
COCHEnvoy Medical, Inc. Press release Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology Newsfile Corp
COCHEnvoy Medical, Inc. Press release Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant Newsfile Corp
COCHEnvoy Medical, Inc. Press release Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant Newsfile Corp
COCHEnvoy Medical, Inc. Press release Envoy Medical Appoints Chas McKhann to Board of Directors Newsfile Corp
COCHEnvoy Medical, Inc. Press release Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant Newsfile Corp
FAQ

Questions about Envoy Medical, Inc.

What does Envoy Medical, Inc. do?
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. The company was founded in 1995 and is based in White Bear Lake, Minnesota. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004.
What is COCH's market cap?
Envoy Medical, Inc. (COCH) is a listed stock with a live quote. The latest market cap on this page is $482M.
Where is Envoy Medical, Inc. headquartered?
Envoy Medical, Inc. is headquartered in White Bear Lake, MN.
How do I get COCH news from the API?
Call GET /v1/news?tickers=COCH. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does COCH news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for COCH, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the COCH price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.